Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management
Opsin Biotherapeutics has raised $328K in total funding. The most recent round was Grant. The last funding was announced in July 2023.
Opsin Biotherapeutics's investors include MassChallenge, National Institutes of Health, National Institute of Neurological Disorders and Stroke.
Opsin Biotherapeutics is headquartered in Bedford, United States.
Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management
Opsin Biotherapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Opsin Biotherapeutics — Funding & Investors." VCBacked, July 27, 2023, https://www.vcbacked.co/company/opsin-biotherapeutics. Accessed July 20, 2026.
VCBacked. (2023). Opsin Biotherapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/opsin-biotherapeutics
{{cite web |title=Opsin Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/opsin-biotherapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated